newsfilter
← Latest News
PR Newswire·

NeuroSense Provides Update on Nasdaq Listing Compliance

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing...